40 Participants Needed

MicroRNA Regulation for Chronic Inflammation

MD
Overseen ByMicah Drummond, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how immune cells in the blood contribute to inflammation as people age. By studying this process, researchers hope to find better ways to reduce inflammation-related health issues. The trial seeks healthy individuals aged 18-35 and 65 and older with a BMI under 30 and in good general health. Participants will undergo simple tests, including blood draws and an exercise test, over a month. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could improve health outcomes for aging populations.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are using chronic anti-inflammatory medications or corticosteroids, you may need to stop them at least 4 weeks before joining the study.

Why are researchers excited about this trial?

Researchers are excited about exploring microRNA regulation's role in chronic inflammation during aging because it offers a fresh perspective compared to standard treatments. Unlike conventional anti-inflammatory drugs, which often target symptoms, this approach delves into the genetic regulation of inflammation. MicroRNA can potentially control the expression of genes involved in inflammation, offering a more precise and potentially effective method to manage chronic inflammation. By understanding how microRNA influences these processes, scientists hope to uncover new strategies to maintain health as we age.

Who Is on the Research Team?

MD

Micah Drummond

Principal Investigator

The University of Utah

Are You a Good Fit for This Trial?

Inclusion Criteria

Age between 18 - 35y; 65y and older
BMI: <30 kg/m2
Ability to sign informed consent
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 hour
1 visit (in-person)

Baseline Assessment

Participants undergo an oral glucose tolerance test, blood draws, and leg strength & exercise tests

3 hours
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after baseline assessments

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Observational Study

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Utah

Lead Sponsor

Trials
1,169
Recruited
1,623,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity